Advertisement
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
Pred 338 dňami
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
Pred 709 dňami
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
Pred 1036 dňami
U.S. Dollar Rises Amid Easing Trade Tensions, Trump's Stance On Powell
The U.S. dollar strengthened against its major counterparts in the New York session on Wednesday, amid optimism about easing trade tensions between the U.S. and China and President Donald Trump appeared to soften his stance on Federal Reserve Chair Jerome Powell.
RTTNews
|
Pred 1 h 23 min
Swiss Market Closes On Upbeat Note
The Switzerland market closed on an upbeat note on Wednesday, in line with markets across Europe, as investors reacted positively to U.S. President Donald Trump softening his tone toward Fed Chair Jerome Powell, and tariffs against China.
RTTNews
|
Pred 3 h 22 min
European Markets Close On Buoyant Note As Trade Tensions Ease
European stocks closed on a strong note on Wednesday as U.S. President Donald Trump toned down his rhetoric on Jerome Powell, and also admitted that the proposed tariffs on China are "very high."
Trump said he would like to see Powell to be a little more active in terms of his idea to lower interest rates, and that he has no intention to fire him.
RTTNews
|
Pred 3 h 35 min
Canadian Market Notably Higher Despite Paring Some Early Gains
The Canadian market is up firmly in positive territory in early afternoon trades on Wednesday, holding on to a significant portion of its gains, amid easing concerns about tariffs and U.S. President Donald Trump softening his stance against Federal Reserve Chair Jerome Powell.
RTTNews
|
Pred 4 h 26 min
U.S. New Home Sales Surge Much More Than Expected In March
New home sales in the U.S. surged by much more than expected in the month of March, according to a report released by the Commerce Department on Wednesday. The Commerce Department said new home sales spiked by 7.4 percent to an annual rate of 724,000 in March after jumping by 3.1 percent to a revised rate of 674,000 in February.
RTTNews
|
Pred 6 h 50 min
